Actively Recruiting
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
Led by Second Xiangya Hospital of Central South University · Updated on 2025-09-03
400
Participants Needed
10
Research Sites
84 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The GLITTER Study 2 is a cluster randomized trial that will evaluate the impact of comprehensive and intensive management, comprising a team, technology, education, and peer resources, on metabolic control and psychological outcomes in patients with type 1 diabetes.
CONDITIONS
Official Title
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Type 1 Diabetes
- Age 6 years or older
- Duration of disease more than 3 months
- Planned to attend follow-up visits at this hospital within the next year
- Sufficient cognitive ability to operate all study-related devices
- Willing to use continuous glucose monitoring and insulin pumps, upload data, and participate in remote monitoring
- Willing to attend structured education sessions and camp activities on time (intervention group only)
- Willing and able to adhere to the study protocol
- Willing to sign the informed consent form
You will not qualify if you...
- Plan to receive diabetes treatment at other hospitals
- Used an automated insulin delivery system or sensor-augmented pump within 3 months prior to screening
- Refuse to use continuous glucose monitoring or insulin pumps, or refuse data upload and remote monitoring
- Have severe cardiovascular, cerebrovascular, hepatic, or renal diseases; uncontrolled systemic diseases; thyroid diseases; autoimmune diseases; or malignancies
- Diagnosed with hematologic or bleeding disorders
- Received red blood cell transfusions or erythropoiesis-stimulating agents within 3 months prior to screening
- Used any oral, injectable, or intravenous corticosteroids within 8 weeks prior to screening, or plan to use corticosteroids during the trial
- Have severe skin diseases affecting the application sites of continuous glucose monitoring or insulin pump patches
- Have auditory or visual impairments
- Have alcohol or drug abuse
- Plan to receive blood transfusions during the study period
- Plan to undergo elective surgery requiring general anesthesia or dialysis during the study period
- Pregnant women, women planning to become pregnant within 1 year of the study, or breastfeeding women
- Currently participating in or have participated in other drug or device trials within the last 2 weeks
- Considered unsuitable for participation by the investigator, such as history of vision impairment, eating disorders, celiac disease, etc.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 10 locations
1
Department of Endocrinology and Metabolism, Peking University People's Hospital
Beijing, Beijing Municipality, China
Not Yet Recruiting
2
Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University
Quanzhou, Fujian, China
Not Yet Recruiting
3
Department of Endocrinology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University
Shenzhen, Guangdong, China
Not Yet Recruiting
4
Second Department of Endocrinology and Metabolism, Tangshan Gongren Hospital
Tangshan, Hebei, China
Not Yet Recruiting
5
Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology
Luoyang, Henan, China, 471003
Actively Recruiting
6
Department of Endocrinology, Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Not Yet Recruiting
7
Institute of Metabolism and Endocrinology, Second Xiangya Hospital of Centra South University
Changsha, Hunan, China, 410011
Actively Recruiting
8
Department of Endocrinology and Metabolism, Institute of Endocrinology, The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China
Not Yet Recruiting
9
Department of Endocrinology and Metabolism, Laboratory of Diabetes and metabolism research, West China Hospital, Sichuan University
Chengdu, Sichuan, China
Not Yet Recruiting
10
Department of Endocrinology, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health
Hangzhou, Zhejiang, China
Not Yet Recruiting
Research Team
X
Xia Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here